RD TOCRIS一级代理,Z-Guggulsterone供应CAS号39025-23-53570

RD TOCRIS一级代理,Z-Guggulsterone供应CAS号39025-23-5

  • 产品型号:  3570
  • 简单描述
  • RD TOCRIS一级代理,Z-Guggulsterone供应CAS号39025-23-5我公司代理RD产品和tocris产品Z-Guggulsterone货号:3570规格:10mg,50mg
详细介绍

RD TOCRIS一级代理,Z-Guggulsterone供应CAS号39025-23-5

Catalog Number: 3570

Chemical Name: (Z)-Pregna-4,17(20)-diene-3,16-dione

详细产品信息:

Biological Activity
Broad spectrum steroid receptor ligand; mineralocorticoid, progesterone and glucocorticoid receptor antagonist (Ki values are 37, 224 and 252 nM respectively) and weak androgen receptor agonist (Ki = 315 nM). Induces apoptosis in prostate cancer cells and inhibits angiogenesis via suppression of the VEGF-VEGFR2-Akt signaling pathway. Exhibits antilipidemic activity via antagonism of the farnesoid X receptor (FXR) and displays antiseptic, antirheumatic and anti-inflammatory activity in vivo. More active isomer of guggulsterone (Cat. No. 2013).

Technical Data

  • M.Wt:

    312.45

  • Formula:

    C21H28O2

  • Solubility:

    Soluble to 20 mM in DMSO with gentle warming and to 10 mM in ethanol with gentle warming

  • Purity:

    >98%

  • Storage:

    Store at RT

  • CAS No:

    39025-23-5

The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis. All Tocris products are intended for laboratory research use only.

R&D供应商Recombinant Rat FGF basic 重组大鼠碱性成纤维细胞生长因子RD 3339-FB-025

R&D供应商Recombinant Rat FGF basic 重组大鼠碱性成纤维细胞生长因子

  • 产品型号:  RD 3339-FB-025
  • 简单描述
  • Recombinant Rat FGF basic ,Recombinant Human FGF basic ,Recombinant Human KGF/FGF-7,Recombinant Human/Mouse FGF-8b
详细介绍

DESCRIPTION
Source E. coliderived
Ala11Ser154
Accession # P13109
Nterminal
Sequence
Analysis
Ala11
Predicted Molecular
Mass
16.2 kDa
SPECIFICATIONS
Activity Measured in a cell proliferation assay using NR6R-3T3 mouse fibroblast cells. Rizzino, A. et al. (1988) Cancer Res. 48:4266; Thomas, K. et
al. (1987) Methods Enzymol. 147:120.
The ED50 for this effect is typically 0.31.8
ng/mL.
Endotoxin Level <1.0 EU per 1 μg of the protein by the LAL method.
Purity >95%, by SDSPAGE
under reducing conditions and visualized by silver stain.
Formulation Lyophilized from a 0.2 μm filtered solution in MOPS, Na2SO4, EDTA and DTT with BSA as a carrier protein. See Certificate of Analysis for
details.
PREPARATION AND STORAGE
Reconstitution Reconstitute at 100 μg/mL in sterile PBS containing at least 0.1% human or bovine serum albumin.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediay at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freezethaw
cycles.
l 12 months from date of receipt, 20
to 70
°C as supplied.
l 1 month, 2 to 8 °C under sterile conditions after reconstitution.
l 3 months, 20
to 70
°C under sterile conditions after reconstitution.
BACKGROUND
FGF basic (FGF2,
HBGF2)
is one of at least 22 mitogenic proteins of the FGF family, which show 35 60%
amino acid conservation (1 3).
Unlike other FGFs,
FGF acidic and basic lack signal peptides and are secreted by an alternate pathway. Storage pools within the cell or on cell surface heparan sulfate proteoglycans
(HSPG) are likely. The predicted 18 kDa FGF basic isoform can be located in both the cytoplasm and the nucleus and is presumed to be the form secreted (4).
Transcription from alternate start sites produces 21 23
kDa forms found only in the nucleus. High and low molecular weight human FGF basic targets the expression
of different genes when expressed in NIH3T3
cells (5). The 18 kDa rat sequence has 98% amino acid (aa) identity with mouse, and 96 97%
aa identity with human,
bovine and sheep FGF basic (6, 7). Autocrine, intracrine and paracrine actions of FGF basic have been identified. Binding of FGF to heparin or cell surface HSPG is
necessary for binding, dimerization and activation of tyrosine kinase FGF receptors. FGF basic binds other proteins, polysaccharides and lipids with lower affinity (3).
Expression of FGF basic is nearly ubiquitous but disruption of the mouse FGF basic gene gives a relatively mild phenotype, suggesting compensation by other FGF
family members. FGF basic modulates such normal processes as angiogenesis, wound healing and tissue repair, embryonic development and differentiation, neuronal
function and neural degeneration. Transgenic overexpression of FGF basic results in excessive proliferation and angiogenesis reminiscent of a variety of pathological
conditions (1 3).
References:
1. Coulier, F. et al. (1997) J. Mol. Evol. 44:43.
2. Fernig, D. et al. (1994) Prog. Growth Factor Res. 5:353.
3. Presta, M. et al. (2005) Cytokine Growth Factor Rev. 16:159.
4. Claus, P. et al. (2003) J. Biol. Chem. 278:479.
5. Quarto, N. et al. (2005) Gene 356:49.
6. Tsuneto, M. et al. (2005) Biochem. Biophys. Res. Commun. 335:1239.
7. Shimasaki, S. et al. (1988) Biochem. Biophys. Res. Commun. 157:256.
Recombinant Rat FGF basic
Catalog Number: 3339-FB
 

 

R&D代理Recombinant Rat EGF重组鼠表皮生长因子RD供应*3214-EG-100

R&D代理Recombinant Rat EGF重组鼠表皮生长因子RD供应*

  • 产品型号:  3214-EG-100
  • 简单描述
  • 此类产品还有人的表皮细胞生长因子,上海利民实业有限公司是华东区RD代理,咨询产品 纤细说明书见详细介绍
详细介绍

DESCRIPTION
Source E. coliderived
Asn974Arg1026,
with an Nterminal
Met
Accession # P07522
Nterminal
Sequence
Analysis
Met
Predicted Molecular
Mass
6.3 kDa
SPECIFICATIONS
Activity Measured in a cell proliferation assay using Balb/3T3 mouse embryonic fibroblast cells. Rubin, J.S. et al. (1991) Proc. Natl. Acad. Sci. USA
88:415.
The ED50 for this effect is typically 1060
pg/mL.
Endotoxin Level <1.0 EU per 1 μg of the protein by the LAL method.
Purity >97%, by SDSPAGE
under reducing conditions and visualized by silver stain.
Formulation Lyophilized from a 0.2 μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein. See Certificate of Analysis for details.
PREPARATION AND STORAGE
Reconstitution Reconstitute at 100 μg/mL in sterile 10 mM Acetic Acid containing at least 0.1% human or bovine serum albumin.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediay at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freezethaw
cycles.
l 12 months from date of receipt, 20
to 70
°C as supplied.
l 1 month, 2 to 8 °C under sterile conditions after reconstitution.
l 3 months, 20
to 70
°C under sterile conditions after reconstitution.
BACKGROUND
Epidermal growth factor (EGF) is the founding member of the EGF family that also includes TGFα,
amphiregulin (AR), betacellulin (BTC), epiregulin (EPR), heparinbinding
EGFlike
growth factor(HBEGF),
epigen, and the neuregulins (NRG)1
through 6
(1). Members of the EGF family share a structural motif, the EGFlike
domain, which is characterized by three intramolecular disulfide bonds that are formed by six similarly spaced conserved cysteine residues (2). All EGF family
members are synthesized as type I transmembrane precursor proteins that may contain several EGF domains in the extracellular region. The mature proteins are
released from the cell surface by regulated proteolysis (1). The 1133 amino acid (aa) rat EGF precursor contains nine EGF domains and nine LDLR class B repeats.
The mature protein consists of 53 aa and is generated by proteolytic excision of the EGF domain proximal to the transmembrane region (3). Mature rat EGF shares
70% and 77% aa sequence identity with mature human and mouse EGF, respectively. EGF is present in various body fluids, including blood, milk, urine, saliva,
seminal fluid, pancreatic juice, cerebrospinal fluid, and amniotic fluid (4). Four ErbB (HER) family receptor tyrosine kinases including EGFR/ErbB1, ErbB2, ErbB3 and
ErbB4, mediate responses to EGF family members (5). These receptors undergo a complex pattern of ligand induced homoor
heterodimerization
to transduce EGF
family signals (6, 7). EGF binds ErbB1 and depending on the context, induces the formation of homodimers or heterodimers containing ErbB2. Dimerization results in
autophosphorylation of the receptor at specific tyrosine residues to create docking sites for a variety of signaling molecules (5, 8). Biological activities ascribed to
EGF include epithelial development, angiogenesis, inhibition of gastric acid secretion, fibroblast proliferation, and colony formation of epidermal cells in culture.
References:
1. Harris, R.C. et al. (2003) Exp. Cell Res. 284:2.
2. Carpenter, G. and Cohen, S. (1990) J. Biol. Chem. 265:7709.
3. Saggi, S.J. et al. (1992) DNA Cell Biol. 11:481.
4. Carpenter, G. and Zendegui, J.G. (1986) Exp. Cell Res. 164:1.
5. Jorissen, R.N. et al. (2003) Exp. Cell Res. 284:31.
6. Gamett, D.C. et al. (1997) J. Biol. Chem. 272:12052.
7. Qian, X. et al. (1994) Proc. Natl. Acad. Sci. 91:1500.
8. Qian, X. et al. (1999) J. Biol. Chem. 274:574.
Recombinant Rat EGF
Catalog Number: 3214-EG
www.

RD Recombinant human IL-17A人白介17因子314-ml-025

RD Recombinant human IL-17A人白介17因子

  • 产品型号:  314-ml-025
  • 简单描述
  • RD Recombinant human IL-17A人白介17因子Source E. coliderived此产品还有小鼠IL-17A
详细介绍

RD Recombinant human IL-17A人白介17因子

DESCRIPTION
Source E. coliderived
Thr22Ala158
Accession # Q62386.1
Nterminal
Sequence
Analysis
Thr22
Structure / Form Disulfidelinked
homodimer
Predicted Molecular
Mass
15.5 kDa (monomer)
SPECIFICATIONS
Activity Measured by its ability to induce IL6
secretion by NIH-3T3 mouse embryonic fibroblast cells. Yao, Z. et al. (1995) Immunity 3:811.
The ED50 for this effect is typically 0.251.25
ng/mL.
Endotoxin Level <1.0 EU per 1 μg of the protein by the LAL method.
Purity >97%, by SDSPAGE
under reducing conditions and visualized by silver stain.
Formulation Lyophilized from a 0.2 μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein. See Certificate of Analysis for details.
PREPARATION AND STORAGE
Reconstitution Reconstitute at 25 μg/mL in sterile 4 mM HCl containing at least 0.1% human or bovine serum albumin.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediay at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freezethaw
cycles.
l 12 months from date of receipt, 20
to 70
°C as supplied.
l 1 month, 2 to 8 °C under sterile conditions after reconstitution.
l 3 months, 20
to 70
°C under sterile conditions after reconstitution.
BACKGROUND
Interleukin 17 (also known as CTLA8)
is a T cellexpressed
pleiotropic cytokine that exhibits a high degree of homology to a protein encoded by the ORF13 gene of
herpesvirus Saimiri. cDNA clones encoding IL17
have been isolated from activated rat, mouse and human T cells. Mouse IL17
cDNA encodes a 158 amino acid (aa)
residue precursor protein with a 21 amino acid residue signal peptide that is cleaved to yield the 137 aa residue mature IL17.
Both recombinant and natural IL17
have
been shown to exist as disulfide linked homodimers. At the amino acid level, mIL17
shows 57% and 87% sequence identity with herpesvirus and rat IL17,
respectively. An IL17
specific mouse cell surface receptor (IL17
R) has been cloned. While the expression of IL17
mRNA is restricted to activated alpha beta
TCR+CD4CD8T
cells, the expression of mIL17
R mRNA has been detected in virtually all cells and tissues tested. IL17
exhibits multiple biological activities on a
variety of cells including: the induction of IL6
and IL8
production in fibroblasts? the enhancement of surface expression of ICAM1
in fibroblasts? activation of NFκB
and costimulation of T cell proliferation.
References:
1. Kennedy, J. et al., (1996) J. Interferon Cytokine Res. 16:611.
2. Yao, Z. et al., (1995) J. Immunol. 155:5483.
3. Yao, Z. et al., (1995) Immunity 3:811.
4. Rouvier, E. et al., (1993) J. Immunol. 150:5445.

RD Recombinant human IL-17A人白介17因子 详细产品信息可和选购